Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Predictive effect of triglyceride‑glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China

Fig. 3

Forest plot of composite MACCEs according to different subgroups. Adjusted model included age, gender, BMI, SBP, DBP, previous MI, past PCI, history of stroke, current/ex-smoker, WBC, eGFR, albumin, TC, TGs, HDL-C, LDL-C, LVEF, hemoglobin, medication used before admission(antiplatelet agent, ACEI/ARB, beta-blocker and statins), in-hospital treatment(PCI/CABG, antiplatelet agent, ACEI/ARB, beta-blocker and statins) and hypoglycemic agents(metformin, alpha-glucosidase inhibitor, DPP-4i and insulin). MACCE, major adverse cardiac and cerebral events; TyG, triglyceride-glucose index; BMI, body mass index; HT, hypertension; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; NSTEMI, Non-ST-segment elevation myocardial infarction; STEMI, ST-elevation myocardial infarction; SBP, systolic blood pressure; DBP, diastolic blood pressure; MI, myocardial infarction; PCI, percutaneous coronary intervention; WBC, white blood cell; TC, total cholesterol; TGs, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; ACEI/ARB, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; CABG, coronary artery bypass graft; DPP-4i, dipeptidyl peptidase-4 inhibitor; HR, hazard ratio; CI, confidence interval; Ref., reference(TyG ≤ 8.91 group)

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840